GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » North China Pharmaceutical Co Ltd (SHSE:600812) » Definitions » Price-to-Funds-From-Operations

North China Pharmaceutical Co (SHSE:600812) Price-to-Funds-From-Operations : (As of Jun. 17, 2024)


View and export this data going back to 1994. Start your Free Trial

What is North China Pharmaceutical Co Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


North China Pharmaceutical Co (SHSE:600812) Business Description

Traded in Other Exchanges
N/A
Address
No. 388 Heping East Road, Shijiazhuang, Hebei, CHN, 050015
North China Pharmaceutical Co Ltd is engaged in the manufacture and sale of antibiotics, vitamins, and pharmaceutical products in China. The main products include antibiotics such as penicillin, vitamins, cephalosporins, streptomycin, biotechnological drugs, new preparations, and biological products.
Executives
Gao Ren Long senior management
Lian Fa Zhe Director